212 related articles for article (PubMed ID: 9174873)
1. Advances in dermatopharmacology--strength and weakness of recently of approved drugs (I).
Chang YC; Maibach HI
Int J Clin Pharmacol Ther; 1997 May; 35(5):188-94. PubMed ID: 9174873
[No Abstract] [Full Text] [Related]
2. Drug treatments for skin disease introduced in 2006.
Skin Therapy Lett; 2007 May; 12(4):4-7. PubMed ID: 17551663
[TBL] [Abstract][Full Text] [Related]
3. Generic drugs--safe, effective, and affordable.
Peters JR; Hixon DR; Conner DP; Davit BM; Catterson DM; Parise CM
Dermatol Ther; 2009; 22(3):229-40. PubMed ID: 19453347
[TBL] [Abstract][Full Text] [Related]
4. Finding, evaluating, and managing drug-related risks: approaches taken by the US Food and Drug Administration (FDA).
Weaver J; Grenade LL; Kwon H; Avigan M
Dermatol Ther; 2009; 22(3):204-15. PubMed ID: 19453344
[TBL] [Abstract][Full Text] [Related]
5. Off-label uses of biologic agents in dermatology: a 2006 update.
Kerns MJ; Graves JE; Smith DI; Heffernan MP
Semin Cutan Med Surg; 2006 Dec; 25(4):226-40. PubMed ID: 17174843
[TBL] [Abstract][Full Text] [Related]
6. Drugs and other product choices.
Hyman PM; Carvajal R
Dermatol Ther; 2009; 22(3):216-24. PubMed ID: 19453345
[TBL] [Abstract][Full Text] [Related]
7. Sources of drug information: FDA-approved labeling and other official FDA sources.
Lindstrom JA
Dermatol Ther; 2009; 22(3):246-56. PubMed ID: 19453349
[TBL] [Abstract][Full Text] [Related]
8. Antihelmintic and antiparasitic drugs: unapproved uses or indications.
Goihman-Yahr M
Clin Dermatol; 2000; 18(1):113-7. PubMed ID: 10701092
[No Abstract] [Full Text] [Related]
9. Retinoids: unapproved uses or indications.
Arechalde A; Saurat JH
Clin Dermatol; 2000; 18(1):63-76. PubMed ID: 10701087
[No Abstract] [Full Text] [Related]
10. FDA news. Food and Drug Administration.
Res Initiat Treat Action; 1999 Jan; 5(1):20. PubMed ID: 11366229
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressant and cytotoxic drugs: unapproved uses or indications.
Abel EA
Clin Dermatol; 2000; 18(1):95-101. PubMed ID: 10701090
[No Abstract] [Full Text] [Related]
12. Antimalarials: unapproved uses or indications.
Wolf R; Wolf D; Ruocco V
Clin Dermatol; 2000; 18(1):17-35. PubMed ID: 10701084
[No Abstract] [Full Text] [Related]
13. Phototherapy, photochemotherapy, and photodynamic therapy: unapproved uses or indications.
Ledo E; Ledo A
Clin Dermatol; 2000; 18(1):77-86. PubMed ID: 10701088
[No Abstract] [Full Text] [Related]
14. Dapsone: unapproved uses or indications.
Wolf R; Tüzün B; Tüzün Y
Clin Dermatol; 2000; 18(1):37-53. PubMed ID: 10701085
[No Abstract] [Full Text] [Related]
15. Off-label use of prescription drugs.
Hill M
Dermatol Nurs; 2000 Aug; 12(4):238, 256. PubMed ID: 11912659
[No Abstract] [Full Text] [Related]
16. Drug treatments for skin disease introduced in 2009.
Skin Therapy Lett; 2010 Feb; 15(2):6-7. PubMed ID: 20361170
[No Abstract] [Full Text] [Related]
17. Antibiotics: unapproved uses or indications.
Sadick NS
Clin Dermatol; 2000; 18(1):11-6. PubMed ID: 10701083
[No Abstract] [Full Text] [Related]
18. Off-label dermatologic therapies. Usage, risks, and mechanisms.
Li VW; Jaffe MP; Li WW; Haynes HA
Arch Dermatol; 1998 Nov; 134(11):1449-54. PubMed ID: 9828883
[TBL] [Abstract][Full Text] [Related]
19. Clarification: 510k is premarket notification; it provides no patent or FDA approval.
Burkhart CG
J Drugs Dermatol; 2008 Feb; 7(2):105. PubMed ID: 18335644
[No Abstract] [Full Text] [Related]
20. Kaposi's sarcoma: new topical treatment approved.
James JS
AIDS Treat News; 1999 Feb; (No 313):1. PubMed ID: 11366235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
